Category: Washington, D.C.
-
D.C. Cannabis Industry unites ahead of pivotal regulatory shift
A recent industry mixer brought together members of the D.C. medical cannabis market to promote unity and collaboration ahead of a key regulatory deadline. Attendees emphasized the need to address historical fragmentation and regulatory inconsistencies.
-
Trump’s D.C. task force targets “failed Policies,” including cannabis decriminalization
President Trump creates the D.C. Safe and Beautiful Task Force to combat crime in the nation’s capital, citing “failed policies” such as the decriminalization of cannabis as a contributing factor.
-
As little as 10% of unlicensed D.C. cannabis shops set to transition to legal medical market
Even if half of the shops who made it to the license docket make Monday’s open deadline, a little over 30% of unlicensed applicants will have made the transition to the legal D.C. market. That’s as little as 10% of the entire cannabis gifting market in D.C. if considering the number of unlicensed shop according…
-
Another placarded D.C. cannabis shop, padlocked for unlicensed sales
D.C. authorities shut down Sheridan International Market for operating as an unlicensed cannabis retailer, seizing over five pounds of illegal cannabis products. The location, also linked to a pending medical cannabis license, was deemed a public safety hazard.
-
Unlicensed Adams Morgan cannabis store shut down a third time
An unlicensed cannabis shop in D.C. was padlocked for a second time in the same location after allegedly continuing to offer unlicensed cannabis. Kaliiva made headlines a year ago after being one of the first few shops to be raided despite committing to transition to the legal market. Unlicensed shops were given safe harbor from…
-
D.C. medical cannabis market sees new patient growth and market expansion
D.C.’s medical cannabis market grew in February 2025 with more dispensaries and patients, but sales per patient decreased. Vape sales rose significantly, while concentrate profits and flower sales dropped. The market also faces upcoming patient certification expirations.
-
Placarded, unlicensed D.C. cannabis shop shutdown
D.C. authorities closed Apple Dreamz, an unlicensed cannabis retailer, on March 13, 2025, due to public safety concerns. Despite receiving a placard for a licensed medical dispensary in June 2024, the business continued to operate illegally, leading to the closure order and padlocking of the premises.
-
Over 35 unlicensed cannabis shops face Mar. 31 deadline for legal open
Only 14 of over 70 D.C. unlicensed cannabis “gifting” shops have transitioned to the legal medical market by March 14, 2025, despite a 2023 opportunity. With a March 31, 2025 deadline looming, 19 licensed but unopened businesses and 15 pending applicants face closure if they don’t open.
-
Six months after orders to close, two unlicensed D.C. cannabis stores padlocked
Two unlicensed stores padlocked more than half a year after receiving cease and desist orders from authorities.
-
Ex-owner of D.C. dispensary suing I-71 businesses indicted for almost $1M in federal tax evasion
Jennifer Brunenkant, owner of D.C. cannabis dispensary Herbal Alternatives II, has been indicted on federal tax evasion charges, including failing to report millions in revenue and evading roughly $800,000 in income taxes, as well as $130,000 in employment taxes.
-
Arrests continue in unlicensed D.C. cannabis shop closures
D.C. authorities shut down an illegal cannabis shop in Northeast, arresting two individuals and seizing a large quantity of drugs including cannabis, mushrooms and cocaine. The closure, executed by ABCA and MPD, is part of ongoing efforts to enforce regulations against unlicensed cannabis businesses.
-
Emergency legislation passed to solidify unlicensed D.C cannabis shop closure deadline
D.C. Council passed emergency legislation to tighten enforcement against unlicensed cannabis and Schedule I substance sales, including immediate action against those selling drugs like psychedelic mushrooms. It sets an April 2025 deadline for all unlicensed shops, allows action against licensed dispensaries posing risks, and expands testing authority.